We are honored to add the University of Kansas Medical Center (Siddhartha Ganguly, MD, FACP) Kansas City, Kansas to www.myelomasurvival.com. Their performance is truly amazing, because if we adjust the observed survival for patients under the care of Dr. Ganguly, the relative survival rate for two years is 100.1%. What this means is that in the first two years Dr. Ganguly's patients have a better chance of survival than the average American of the same age without multiple myeloma. That is a truly remarkable performance. Dr. Ganguly was recommended to me by another exceptional multiple myeloma doctor. I find that great doctors know who the other great doctors are, and I will continue to ask myeloma specialists for their recommendations.
In addition, you are 3.3 times more likely to survive 4 years, when compared to the average SEER facility. They have provided their transplant experience over the past 5 years and report a 2 year relative survival rate of 100.1% versus the SEER data of 64.1%, and a 4 year relative survival rate of 84.8% versus the SEER survival rate of 49.2%. Therefore, receiving care through Dr. Ganguly, Director of the Myeloma/Lymphoma Program at the University of Kansas Medical Center, is one of the very best options for patients with multiple myeloma in the Midwest region.
The Midwest continues to impress me with the quality of care that is available for the myeloma patient community. Many excellent programs like Dr. Ganguly's of University of Kansas, Dr. Faber of University of Nebraska, and Dr. Hari's of the Medical College of Wisconsin just were not on my radar or that of the multiple myeloma patient community at large. Thank You Dr. Ganguly for opening up my eyes to another superior multiple myeloma program.
Brief bio of Dr. Siddhartha Ganhuly
Siddhartha Ganguly, M.D., FACP
Rank: Associate Professor of Medicine
Education and Training:
Medical School: Post Graduate Institute of Medical Education and Research, Chandigarh, India (Doctor of Medicine)
Internship: Southern Illinois University School of Medicine, Springfield, IL
Residency: Senior Resident Institute Chandigarh, India
Residency: Baylor College of Medicine, Houston, TX (Internal Medicine)
Fellowship: GB Pant Hospital, Delhi University, New Delhi, India (Post-Doctoral Fellow (DM) Doctorate of Medicine)
Fellowship: Baylor College of Medicine, Houston, Texas (Hematology)
Fellowship: Baylor College of Medicine Center for Cell and Gene Marrow Transplantation Therapy, Houston, Texas (Bone Marrow Transplant)
Awards:
• National Talent Search Scholarship, Government of India
• Anatomy, Medical College, University of Calcutta, India, Senior Prosector
• Goodeve Silver Medal, Medical College, University of Calcutta, India
• Gold Medal, Anatomy, Medical College, University of Calcutta, India
• Pathology, Medical College, University of Calcutta, India, Senior Class Assistant
• Medicine, Medical College, University of Calcutta, India, Senior Class Assistant
• Successive Four College Scholarships, Medical College, University of Calcutta, India
Organizations:
• American Medical Association
• American College of Physicians
• American Society for Blood and Marrow Transplantation
• American Society of Hematology
• American College of Physicians - Elected Fellow (FACP)
Clinical Interest(s):
• Bone Marrow Transplantation
• Stem Cell Transplantation
• Hematological Malignancies
• Lymphoma
• Multiple Myeloma
Research Interest(s):
• Clinical Research in Hematologic Malignancies
• Consultative benign hematology
• Stem cell and marrow transplantation
In addition, you are 3.3 times more likely to survive 4 years, when compared to the average SEER facility. They have provided their transplant experience over the past 5 years and report a 2 year relative survival rate of 100.1% versus the SEER data of 64.1%, and a 4 year relative survival rate of 84.8% versus the SEER survival rate of 49.2%. Therefore, receiving care through Dr. Ganguly, Director of the Myeloma/Lymphoma Program at the University of Kansas Medical Center, is one of the very best options for patients with multiple myeloma in the Midwest region.
The Midwest continues to impress me with the quality of care that is available for the myeloma patient community. Many excellent programs like Dr. Ganguly's of University of Kansas, Dr. Faber of University of Nebraska, and Dr. Hari's of the Medical College of Wisconsin just were not on my radar or that of the multiple myeloma patient community at large. Thank You Dr. Ganguly for opening up my eyes to another superior multiple myeloma program.
Brief bio of Dr. Siddhartha Ganhuly
Siddhartha Ganguly, M.D., FACP
Rank: Associate Professor of Medicine
Education and Training:
Medical School: Post Graduate Institute of Medical Education and Research, Chandigarh, India (Doctor of Medicine)
Internship: Southern Illinois University School of Medicine, Springfield, IL
Residency: Senior Resident Institute Chandigarh, India
Residency: Baylor College of Medicine, Houston, TX (Internal Medicine)
Fellowship: GB Pant Hospital, Delhi University, New Delhi, India (Post-Doctoral Fellow (DM) Doctorate of Medicine)
Fellowship: Baylor College of Medicine, Houston, Texas (Hematology)
Fellowship: Baylor College of Medicine Center for Cell and Gene Marrow Transplantation Therapy, Houston, Texas (Bone Marrow Transplant)
Awards:
• National Talent Search Scholarship, Government of India
• Anatomy, Medical College, University of Calcutta, India, Senior Prosector
• Goodeve Silver Medal, Medical College, University of Calcutta, India
• Gold Medal, Anatomy, Medical College, University of Calcutta, India
• Pathology, Medical College, University of Calcutta, India, Senior Class Assistant
• Medicine, Medical College, University of Calcutta, India, Senior Class Assistant
• Successive Four College Scholarships, Medical College, University of Calcutta, India
Organizations:
• American Medical Association
• American College of Physicians
• American Society for Blood and Marrow Transplantation
• American Society of Hematology
• American College of Physicians - Elected Fellow (FACP)
Clinical Interest(s):
• Bone Marrow Transplantation
• Stem Cell Transplantation
• Hematological Malignancies
• Lymphoma
• Multiple Myeloma
Research Interest(s):
• Clinical Research in Hematologic Malignancies
• Consultative benign hematology
• Stem cell and marrow transplantation
RSS Feed